AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21203694 — intervention group
Group type: EXPERIMENTAL
Intervention: Bungee jumping
Number of subjects: 20
Study 21203694 — intervention group
Group type: COMPARATOR
Intervention: Propranolol pretreatment for 3 days
Number of subjects: 20
Study 18484559 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate insulin infusion (0.8 microU/kg/min)
Number of subjects: 16
Study 18484559 — intervention group
Group type: COMPARATOR
Intervention: High insulin infusion (1.6 microU/kg/min)
Number of subjects: 16
Study 18484559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (blood glucose lowered to 2.5 mmol/l)
Number of subjects: 16
Study 16174656 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg tid)
Number of subjects: 15
Study 16174656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 14662282 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET-guided therapy
Number of subjects: 206
Study 14662282 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 206
Study 11451177 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV vaccination (preS2/S, GenHevac B, Pasteur‐Mérieux), 20 microg, five intramuscular injections
Number of subjects: 118
Study 11451177 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV vaccination (S vaccine, Recombivax Merck & Co.), five intramuscular injections
Number of subjects: 118
Study 11451177 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 118
Study 11451177 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV vaccination (any vaccine), five injections
Number of subjects: 118
Study 11451177 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV vaccination (any vaccine)
Number of subjects: 118
Study 11451177 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 118
Study 9749236 — intervention group
Group type: EXPERIMENTAL
Intervention: Desynchronised mode of extracorporal lithotripsy
Number of subjects: 25
Study 9749236 — intervention group
Group type: COMPARATOR
Intervention: Synchronised mode of extracorporal lithotripsy
Number of subjects: 25
Study 7799770 — intervention group
Group type: COMPARATOR
Intervention: 20 g.l‐1 glucose solution
Number of subjects: 6
Study 7799770 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g.l‐1 glucose solution
Number of subjects: 6
Study 7799770 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g.l‐1 glucose solution
Number of subjects: 6
Study 3288818 — intervention group
Group type: EXPERIMENTAL
Intervention: self-care communication-based health education program
Number of subjects: 0
Study 3288818 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 0
Study 30737338 — intervention group
Group type: EXPERIMENTAL
Intervention: STN-DBS
Number of subjects: 251
Study 30737338 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 251
Study 29031889 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure garment therapy (PGT)
Number of subjects: 40
Study 27680407 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg once daily until disease progression or unacceptable toxicity
Number of subjects: 92
Study 25073663 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon-β1a 125 µg via single-use autoinjector
Number of subjects: 39
Study 25073663 — intervention group
Group type: EXPERIMENTAL
Intervention: single-use autoinjector
Number of subjects: 39
Study 25073663 — intervention group
Group type: COMPARATOR
Intervention: placebo via manual pre-filled syringe (PFS)
Number of subjects: 39
Study 21983985 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysate with low K (2 mmol/L), low Ca (1.25 mmol/L), high bicarbonate (34 mmol)
Number of subjects: 22
Study 21983985 — intervention group
Group type: COMPARATOR
Intervention: Dialysate with high K (3 mmol/L), high Ca (1.75 mmol/L), bicarbonate (30 mmol)
Number of subjects: 22
Study 19923061 — intervention group
Group type: EXPERIMENTAL
Intervention: Premarin (0.3 mg/day and 0.6 mg/day alternately, n=29)
Number of subjects: 57
Study 19923061 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuntai capsule (4 g/day, n=28)
Number of subjects: 57
Study 18086001 — intervention group
Group type: EXPERIMENTAL
Intervention: RLIP76 polymorphisms in the whole cohort
Number of subjects: 503
Study 18086001 — intervention group
Group type: EXPERIMENTAL
Intervention: RLIP76 polymorphisms in a subgroup of patients on carbamazepine
Number of subjects: 503
Study 15345733 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/day micronized 17beta-estradiol (E2)
Number of subjects: 0
Study 15345733 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/day micronized 17beta-estradiol (E2)
Number of subjects: 0
Study 15345733 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/day micronized 17beta-estradiol (E2)
Number of subjects: 0
Study 15345733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11665348 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular toothpaste
Number of subjects: 20
Study 11665348 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan-containing toothpaste
Number of subjects: 20
Study 11665348 — intervention group
Group type: COMPARATOR
Intervention: Control (no toothpaste)
Number of subjects: 20
Study 10209728 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral brovincamine (20 mg three times daily)
Number of subjects: 52
Study 10209728 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 52
Study 8527278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lignocaine
Number of subjects: 8
Study 8527278 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 8
Study 2240348 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 267
Study 2240348 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267
Study 722768 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratings administered immediately before or after the final examination
Number of subjects: 0
Study 722768 — intervention group
Group type: COMPARATOR
Intervention: Mail survey after receiving grades
Number of subjects: 0
Study 722768 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratings from students present on the last two days of class
Number of subjects: 0
Study 31177364 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional technique (fixed anastomosis 200 cm from the ligament of Treitz)
Number of subjects: 60
Study 31177364 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal technique (anastomosis 400 cm from the ileocecal valve)
Number of subjects: 60
Study 31177364 — intervention group
Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 60
Study 28667208 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral letters with checklist assistance
Number of subjects: 25
Study 28667208 — intervention group
Group type: COMPARATOR
Intervention: Referral letters without checklist assistance
Number of subjects: 25
Study 28667208 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklists
Number of subjects: 25
Study 26468479 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin plus oxybutynin
Number of subjects: 59
Study 26468479 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin plus tolterodine
Number of subjects: 59
Study 23536395 — intervention group
Group type: EXPERIMENTAL
Intervention: NODPAM intervention
Number of subjects: 0
Study 23536395 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 21310559 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva manoeuvre
Number of subjects: 150
Study 21310559 — intervention group
Group type: EXPERIMENTAL
Intervention: Handgrip test
Number of subjects: 150
Study 19873916 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (Baihui (GV 20) and Taiyang (EXHN 5), once daily)
Number of subjects: 80
Study 19873916 — intervention group
Group type: COMPARATOR
Intervention: Modified Electric Convulsive Therapy (MECT, treatment once every 2 or 3 days for 14 to 21 days)
Number of subjects: 80
Study 18214053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron conventional tablet (OT) 8 mg twice daily for 3 days
Number of subjects: 134
Study 18214053 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron orally disintegrating tablet (ODT) 8 mg twice daily for 3 days
Number of subjects: 134
Study 15126539 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 5.0 mg
Number of subjects: 399
Study 15126539 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg
Number of subjects: 399
Study 15126539 — intervention group
Group type: COMPARATOR
Intervention: Finasteride 5 mg
Number of subjects: 399
Study 15126539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 11414666 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (6 g daily for three days)
Number of subjects: 0
Study 11414666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11414666 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 0
Study 9598844 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea (6 cups per day)
Number of subjects: 16
Study 9598844 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (6 cups per day)
Number of subjects: 16
Study 9598844 — intervention group
Group type: COMPARATOR
Intervention: Water (control group, 6 cups per day)
Number of subjects: 16
Study 9598844 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea polyphenols (3.6 grams per day)
Number of subjects: 16
Study 9215320 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DHEA daily for 2 weeks
Number of subjects: 40
Study 9215320 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 40
Study 1917031 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (250 mg t.i.d. for seven days)
Number of subjects: 84
Study 1917031 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (250 mg t.i.d. for seven days)
Number of subjects: 84
Study 1917031 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 84
Study 1917031 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin
Number of subjects: 84
Study 7042501 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole prophylactic therapy
Number of subjects: 195
Study 7042501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 31020480 — intervention group
Group type: EXPERIMENTAL
Intervention: IRI + Pmab
Number of subjects: 48
Study 31020480 — intervention group
Group type: COMPARATOR
Intervention: Control (irinotecan, fluoropyrimidines, and panitumumab)
Number of subjects: 48
Study 27912111 — intervention group
Group type: EXPERIMENTAL
Intervention: Ictal-MEG source localization (SL)
Number of subjects: 32
Study 27912111 — intervention group
Group type: COMPARATOR
Intervention: Control (no ictal-MEG data)
Number of subjects: 32
Study 26660491 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% 3-butenyl 5-aminolevulinate gel (ALA-bu)
Number of subjects: 46
Study 26660491 — intervention group
Group type: COMPARATOR
Intervention: Vehicle application (control)
Number of subjects: 46
Study 25539512 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole (100-200mg/day)
Number of subjects: 52
Study 25539512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 25539512 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole responders
Number of subjects: 52
Study 25539512 — intervention group
Group type: COMPARATOR
Intervention: Placebo responders
Number of subjects: 52
Study 25539512 — intervention group
Group type: EXPERIMENTAL
Intervention: FHP riluzole responders
Number of subjects: 52
Study 22425373 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast Cancer Patient Pathway program (Intervention)
Number of subjects: 98
Study 22425373 — intervention group
Group type: COMPARATOR
Intervention: Control group (Control)
Number of subjects: 98
Study 20118007 — intervention group
Group type: EXPERIMENTAL
Intervention: Bile reinfusion group (n=20)
Number of subjects: 40
Study 20118007 — intervention group
Group type: COMPARATOR
Intervention: Exclusive external drainage group (control group, n=20)
Number of subjects: 40
Study 20118007 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 18684279 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR pacing (dual chamber pacing)
Number of subjects: 504
Study 18684279 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing (single chamber pacing)
Number of subjects: 504
Study 15801938 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily for 8 days
Number of subjects: 10
Study 15801938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12579599 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 cyclophosphamide (CY) pulses combined with corticosteroids (CS)
Number of subjects: 65
Study 12579599 — intervention group
Group type: COMPARATOR
Intervention: 6 cyclophosphamide (CY) pulses combined with corticosteroids (CS)
Number of subjects: 65
Study 12579599 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 CY pulses)
Number of subjects: 65
Study 10233489 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid laser treatment (30 W KTP and 60 W Nd:YAG)
Number of subjects: 204
Study 10233489 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 204
Study 9106842 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal encouragement
Number of subjects: 26
Study 9106842 — intervention group
Group type: COMPARATOR
Intervention: No verbal encouragement
Number of subjects: 26
Study 1491486 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-teboroxime (TEBO)
Number of subjects: 194
Study 1491486 — intervention group
Group type: COMPARATOR
Intervention: 201Tl
Number of subjects: 194
Study 2858747 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance monitoring
Number of subjects: 6
Study 2858747 — intervention group
Group type: COMPARATOR
Intervention: Scintigraphy
Number of subjects: 6
Study 31739840 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast sodium chewable tablets combined with inhaled budesonide
Number of subjects: 135
Study 31739840 — intervention group
Group type: COMPARATOR
Intervention: Single-drug group (either montelukast sodium or budesonide)
Number of subjects: 135
Study 30400840 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Endurance Training (HIIT)
Number of subjects: 59
Study 30400840 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention (supervised myofascial release training)
Number of subjects: 59
Study 30400840 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 59
Study 30400840 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 59
Study 26371459 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor training
Number of subjects: 23
Study 26371459 — intervention group
Group type: COMPARATOR
Intervention: Outdoor training
Number of subjects: 23
Study 24595505 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 265
Study 24595505 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate decreasers
Number of subjects: 265
Study 24595505 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong decreasers
Number of subjects: 265
Study 24595505 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 265
Study 22076751 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day for 14 days)
Number of subjects: 60
Study 22076751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 17655985 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersion bath for 60 mins
Number of subjects: 108
Study 17655985 — intervention group
Group type: COMPARATOR
Intervention: Control (non-bathing)
Number of subjects: 108
Study 17615478 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (8 weeks, 35 minutes per session, 4 times per week)
Number of subjects: 39
Study 17615478 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 15090794 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-G*0105N allele
Number of subjects: 431
Study 15090794 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-G*010108 allele
Number of subjects: 431
Study 15090794 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-G*010108/010401 genotype
Number of subjects: 431
Study 15090794 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-G*010101/010108 genotype
Number of subjects: 431
Study 11438814 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) in allogeneic stem cell transplantation
Number of subjects: 0
Study 11438814 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rHuEPO) in autologous stem cell transplantation
Number of subjects: 0
Study 8486041 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous turning on an oscillating air-flotation bed for five days
Number of subjects: 124
Study 8486041 — intervention group
Group type: COMPARATOR
Intervention: Routine turning on a standard ICU bed for five days
Number of subjects: 124
Study 8486041 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous turning on an oscillating air-flotation bed for five days (specifically in SEPSIS DRG)
Number of subjects: 124
Study 8486041 — intervention group
Group type: COMPARATOR
Intervention: Routine turning on a standard ICU bed for five days (specifically in SEPSIS DRG)
Number of subjects: 124
Study 3154674 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg once a day
Number of subjects: 0
Study 3154674 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study 31927665 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal cardioversion through ICD
Number of subjects: 31
Study 31927665 — intervention group
Group type: COMPARATOR
Intervention: External direct current cardioversion (EDCCV)
Number of subjects: 31
Study 29748195 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise training for 10 months
Number of subjects: 61
Study 29748195 — intervention group
Group type: COMPARATOR
Intervention: Yoga (control group)
Number of subjects: 61
Study 28784181 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fructose diet intervention group (LFDI)
Number of subjects: 490
Study 28784181 — intervention group
Group type: COMPARATOR
Intervention: Standard-diet control group (SDC)
Number of subjects: 490
Study 26240230 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human TSH (rhTSH)
Number of subjects: 752
Study 26240230 — intervention group
Group type: COMPARATOR
Intervention: thyroid hormone withdrawal (THW)
Number of subjects: 752
Study 26240230 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 GBq of (131)I
Number of subjects: 752
Study 26240230 — intervention group
Group type: COMPARATOR
Intervention: 3.7 GBq of (131)I
Number of subjects: 752
Study 24116723 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus (STN) stimulation
Number of subjects: 12
Study 24116723 — intervention group
Group type: COMPARATOR
Intervention: Globus pallidus internus (GPi) stimulation
Number of subjects: 12
Study 24116723 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous stimulation of STN and GPi
Number of subjects: 12
Study 24116723 — intervention group
Group type: COMPARATOR
Intervention: GPi stimulation (in patients rated according to TWSTRS)
Number of subjects: 12
Study 24116723 — intervention group
Group type: EXPERIMENTAL
Intervention: STN stimulation (in patients rated according to TWSTRS)
Number of subjects: 12
Study 21974695 — intervention group
Group type: EXPERIMENTAL
Intervention: High hemoglobin target (11.0‐13.0g/dL) with darbepoetin alfa
Number of subjects: 321
Study 21974695 — intervention group
Group type: COMPARATOR
Intervention: Low hemoglobin target (9.0‐11.0g/dL) with recombinant erythropoietin
Number of subjects: 321
Study 18082498 — intervention group
Group type: EXPERIMENTAL
Intervention: Class IC antiarrhythmic drugs (AADs)
Number of subjects: 176
Study 18082498 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 176
Study 18082498 — intervention group
Group type: EXPERIMENTAL
Intervention: Class IC AADs
Number of subjects: 176
Study 16441978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tramadol
Number of subjects: 60
Study 16441978 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac
Number of subjects: 60
Study 14572748 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium(89) Chloride (150MBq, single intravenous injection)
Number of subjects: 203
Study 14572748 — intervention group
Group type: COMPARATOR
Intervention: Local field radiotherapy (usual regimen used at each centre)
Number of subjects: 203
Study 14572748 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium(89) Chloride
Number of subjects: 203
Study 14572748 — intervention group
Group type: COMPARATOR
Intervention: Local field radiotherapy
Number of subjects: 203
Study 10594429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure group with narrow cuff (7 cm)
Number of subjects: 20
Study 10594429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure group with wide cuff (14 cm)
Number of subjects: 20
Study 10594429 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturation group with narrow cuff (7 cm)
Number of subjects: 20
Study 10594429 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturation group with wide cuff (14 cm)
Number of subjects: 20
Study 10594429 — intervention group
Group type: COMPARATOR
Intervention: Pressure group (both cuffs)
Number of subjects: 20
Study 10594429 — intervention group
Group type: COMPARATOR
Intervention: Saturation group (both cuffs)
Number of subjects: 20
Study 9294900 — intervention group
Group type: EXPERIMENTAL
Intervention: Preunit interactions
Number of subjects: 0
Study 8473450 — intervention group
Group type: COMPARATOR
Intervention: 225 IU HMG/day
Number of subjects: 46
Study 8473450 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 IU HMG/day
Number of subjects: 46
Study 3608048 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane in N2O/oxygen, and fentanyl (Group II)
Number of subjects: 20
Study 3608048 — intervention group
Group type: COMPARATOR
Intervention: Enflurane in air/oxygen, and fentanyl (Group I)
Number of subjects: 20